Efficacy of non-medicinal approaches in treating side effects associated with cancer treatment by Caputo, Michael
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2014
Efficacy of non-medicinal
approaches in treating side effects
associated with cancer treatment
https://hdl.handle.net/2144/15310
Boston University
	   	   	  
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
 
EFFICACY OF NON-MEDICINAL APPROACHES IN TREATING 
 
SIDE EFFECTS ASSOCIATED WITH CANCER TREATMENT 
 
 
 
 
by 
 
 
 
 
MICHAEL CAPUTO 
 
B.A., Boston University, 2013 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
2014
	   	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 by 
 MICHAEL CAPUTO 
 All rights reserved
	   	   	  
 
Approved by 
 
 
 
 
First Reader   
 Carl Franzblau, Ph.D. 
 Professor of Biochemistry 
 
 
Second Reader   
 Gwynneth Offner, Ph.D. 
 Director M.A. Medical Sciences Program 
 Associate Professor of Medicine 
	   	   	  
	   iv	  
 
ACKNOWLEDGMENTS 
 There are several people I would like to thank for offering their help and expertise 
in order to help me complete my Master’s in the Medical Sciences. I would like to thank 
the entire faculty and staff of the GMS division of Boston University School of Medicine 
in helping me gain a fundamental knowledge base in the medical sciences. The faculty 
and staff at GMS are all extremely knowledgeable in their respective areas of expertise, 
and they are all very enthusiastic on the subject matters that they teach. 
 Next, I would like to thank my first reader, Dr. Carl Franzblau for all the support 
and insight that he has provided since the start of my journey in the MAMS program. 
Specifically, Dr. Franzblau helped me stay on track in order to meet specific deadlines for 
the submission of my MAMS thesis. His knowledge and expertise have proved to be 
invaluable throughout the process of writing my thesis. 
 I would also like to thank Dr. Gwennyth Offner, my second reader. Dr. Offner is 
one of the greatest assets that the MAMS program has to offer. Dr. Offner was always 
very eager to meet with me throughout my time in the MAMS program, and without her 
help it would have been extremely difficult for me to get through the MAMS program 
within one year. 
 Lastly, I would like to thank my family and friends. My family and friends have 
been the support line I can rely on whenever I needed help. Specifically, my parents and 
my brother Christopher have helped me in not only completing my thesis, but also 
helping me with all the problems I have faced throughout my academic career. 
	   	   	  
	   v	  
 
EFFICACY OF NON-MEDICINAL APPROACHES IN TREATING SIDE 
EFFECTS ASSOCIATED WITH CANCER TREATMENT 
 
MICHAEL CAPUTO 
 
ABSTRACT 	   In the United States, the golden standard of treatment for patients afflicted with 
cancer is adjuvant chemotherapy treatment. Chemotherapy treatment has proven efficacy 
in eradicating cancer cells, but the treatment itself is associated with a variety of negative 
side effects. Side effects such as nausea and vomiting have been effectively treated with 
anti-emetics, but other negative side effects, such as fatigue and reduced quality of life, 
have no proven pharmacologic agents that effectively treat them. The goal of this paper is 
to identify alternative approaches to treat the side effects associated with chemotherapy 
treatment. 
 This paper reviewed a large collection of literature concerned with determining 
the efficacy of exercise, music therapy, and spiritual techniques in reducing the 
magnitude of the negative symptoms associated with chemotherapy treatment. The data 
showed that exercise was the most effective therapy in reducing fatigue in cancer 
patients; meanwhile music therapy and spiritual techniques displayed efficacy in 
improving a patient’s overall quality of life. However, further studies are needed in order 
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to definitively determine the efficacy of exercise, music therapy, and spiritual techniques 
as adjuncts to chemotherapy treatment. 
 This paper concluded that exercise, music therapy, and spiritual techniques have 
the potential to be effective tools that physicians can utilize when helping cancer patients 
alleviate the side effects associated with chemotherapy treatment. Moreover, exercise has 
shown the most evidence, through studies, as being an effective adjunct treatment to 
chemotherapy. Future research should focus on utilizing multiple therapeutic approaches 
in order to reduce the negative side effects associated with chemotherapy treatment. 	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INTRODUCTION 
 The use of chemotherapy to treat cancerous cells arose as a byproduct of the 
Second World War (DeVita & Chu, 2008). While conducting various experiments on 
potential chemical weapon agents, a compound known as nitrogen mustard was 
discovered, and the scientists studying this compound soon realized that nitrogen mustard 
was effective in treating lymphoma. This discovery soon led to the development of 
alkylating agents, which were compounds capable of destroying the DNA of cancerous 
cells. Eventually, in the mid-1970s, a researcher named Bernard Fisher completed the L-
PAM study, which was concerned with the use of chemotherapy as an adjunct to surgery 
or radiation therapy (DeVita & Chu, 2008). The study found that treating cancer cells 
locally with surgery or radiation therapy, and then subsequently treating with 
chemotherapy to prevent secondary tumor formation was a more effective method of 
treatment than treating with chemotherapy alone (DeVita & Chu, 2008).  
 Following the advent of adjuvant chemotherapy treatment as the golden standard 
for cancer treatment, it was soon discovered that chemotherapeutics had multiple adverse 
side effects. Some of the major complaints of cancer patients undergoing chemotherapy 
treatment, besides nausea and vomiting, included fatigue, sleep disturbance, wake 
disturbance, and emotional disturbance-depression (Erickson et al., 2014). Current 
pharmacologic approaches focus on utilizing anti-emetic drugs in order to perturb the 
nausea and vomiting side effects, but there has been a lack of focus within the medical 
field to help subside the several other adverse side effects (Ropper & Samuels, 2009). 
However, recently, there has been a significant push within the medical field to look at 
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the effects of several non-pharmacologic approaches to improve the side effects of 
fatigue and depression. A study by Chalise (n.d.) demonstrated that alternative treatments 
such as exercise, spirituality involvement, and listening to music, were effective therapies 
in reducing the fatigue of cancer patients. However, one major concern from this study 
was the fact that alternative treatments such as spirituality involvement are more 
traditional practices, and the extent of their effectiveness on all cancer patients is unclear 
(Chalise, n.d.). 
 The literature has provided significantly positive evidence that the alternative 
practices of exercise and listening to music are effective in subsiding several of the 
negative side effects of chemotherapy treatment, mainly fatigue. One study conducted by 
Andersen et al. (2013) found that multimodal exercise intervention could reduce self-
reported fatigue in cancer patients. However, a major problem within this study was the 
fact that its participants were comparatively younger, and better educated than the general 
cancer population (Andersen et al., 2013). Furthermore, a study conducted by Jacobsen et 
al. (2013) found that exercise alone fails to improve the depressive side effects associated 
with chemotherapy treatment. The study demonstrated that only combined intervention of 
exercise and self-directed stress management training was successful in improving 
depression, and these results are displayed in figure 1 (Jacobsen et al., 2013). Thus, 
although an exercise routine was successful in reducing fatigue in cancer patients 
undergoing chemotherapy, exercise’s ability to alleviate depression in cancer patients 
was dependent on utilization of self-directed stress management techniques.  
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Figure 1. Depression and Anxiety Scores Decrease with Combined Stress 
Management and Exercise. 286 patients were assessed on depression and anxiety scores 
at 6 and 12 weeks following either usual care or a combination of stress management and 
exercise while undergoing chemotherapy. Figure taken from Jacobsen et al., 2013. 
 
Whereas the literature has found that exercise leads to objective improvements in 
fatigue for cancer patients, studies concerned with listening to music and its effect on 
cancer patients are divided. O’Callaghan et al., (2012) illustrated that for some cancer 
patients, music was effective in improving a patient’s quality of life. However, the study 
also found that some cancer patients found music to induce too many negative emotions 
(O’Callaghan et al., 2012). A significant problem with this study was the fact that most 
participants had a musical background, and thus the results may not represent the effect 
of music on the general cancer population. Another study conducted by Romito et al., 
(2013) provided a small number of breast cancer patients with a single integration 
intervention of music therapy during chemotherapy treatment, and the results 
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demonstrated that music was able to reduce negative emotions felt by these patients, as 
well as improve depressive side effects. 
 The current scientific literature on alternative approaches to treating side effects 
associated with chemotherapy treatment demonstrates that approaches such as exercise 
and listening to music are two viable options that can subside some of the adverse side 
effects of chemotherapy treatment. However, the role of these two alternative treatments 
for treating side effects associated with specific types of chemotherapeutic agents 
remains ambiguous. Moreover, the use of therapies, mainly spiritual involvement, 
remains controversial due to the fact that such therapies depend on the individual being 
treated.  
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BACKGROUND 
What	  is	  Cancer?	   	  	   Cancer arises in individuals, when such individuals experience nonlethal genetic 
damage to certain genes within their genome (Murray, Jacob, & Varghese, 2012). The 
four types of genes that can lead to the development of cancer include: proto-oncogenes, 
tumor suppressor genes, genes involved in DNA repair, and genes involved with the 
apoptotic process (Murray et al., 2012). When one of these four types of genes undergoes 
a mutation, there is an increased risk for the damaged gene to start to multiply, eventually 
resulting in the formation of a malignant tumor (Murray et al., 2012). Figure 1 shows a 
schematic on how proto-oncogenes and tumor suppressor genes can be altered, eventually 
resulting in the development of cancer. The growth rate of a malignant tumor is mainly 
dependent on the specific type of cancer that an individual is afflicted with, and thus, a 
tumor may take anywhere between months to several years in order to develop (Murray 
et al., 2012). 
 
 
Figure 2. Alterations in either Proto-Oncogenes or Tumor Suppressor Genes Leads 
to Cancer. Proto-Oncogenes can become activated and subsequently become Oncogenes 
leading to increased growth rate of cells. Tumor Suppressor genes can become 
inactivated, releasing inhibition of growth, thus resulting in increased growth rate of 
cells. Modified from Murray et al.: Harper’s Illustrated Biochemistry, 29th edition.  
 
Proto-Oncogenes !  Oncogenes 
      !  Increased Growth Rate !!!  Cancer 
Tumor Suppressor !  Inactivated 
Genes 	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 There are several distinguishing features that characterize cancer cells. The first 
distinguishing feature is that cancer cells multiply rapidly, and have a diminished ability 
to control growth (Murray et al., 2012). Cancer cells demonstrate the ability to both 
control their own growth signals, as well as ignore the growth-inhibiting signals from 
outside sources within the body. The proliferation of cancer cells is further supplemented 
by cancer cells’ ability to both stimulate angiogenesis, as well as their ability to avoid 
programmed cell death. Also, cancer cells, when untreated for a long time or after 
becoming insensitive to treatment, have the ability to invade local tissues and 
metastasize. 
 Genetic damage to a person’s genome can be attributed to genetic factors, or the 
mutations can arise from prolonged exposure to carcinogenic substances that pervade 
within the environment (Murray et al., 2012). Genetic mutations leading to malignant 
tumors as a result of hereditary factors account for an estimated 5% of reported cancer 
cases. Specific genes, such as tumor suppressor genes and proto-oncogenes, are the genes 
that are mainly affected by genetic mutations arising from hereditary factors. Though 5% 
of cancer cases arise due to hereditary factors, a majority of reported cancer cases are due 
to exposure to environmental carcinogens, as cited by Murray et al. (2012). Such 
environmental carcinogens include exposure to radiant energy, such as ultraviolet rays, 
exposure to carcinogenic chemical compounds, and exposure to tumor viruses, such as 
the human papilloma virus, which acts by integrating its viral DNA into its host DNA in 
order to disrupt essential processes that are imperative in preventing the development of 
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cancerous cells. Table 1, below, displays several examples of types of environmental 
carcinogens. 
Table 1. Examples of Environmental Carcinogens. Current environmental carcinogens 
that persist in the environment. 
 
Type	  of	  Environmental	  
Carcinogen	  
Examples	  
Radiant Energy Ultraviolet Rays, X-Rays, Gamma Rays 
Carcinogenic Chemical Compounds Polycyclic aromatic hydrocarbons, aromatic amines, 
nitrosamines, various drugs, naturally occurring 
compounds 
Tumor Viruses Epstein-Barr virus, Hepatitis B, Hepatitis C, Human 
herpes virus type I, Human papilloma virus, Human T-
cell leukemia virus type 1 
 
 Of the estimated 95% of cancer cases arising from environmental carcinogens, 
approximately 80% of those cancer cases are the result of exposure to chemical 
compounds (Murray et al., 2012). A few examples of chemical compounds that have 
been implicated in causing cancer in humans include: pesticides, aromatic hydrocarbons, 
and metals (Boers et al., 2005). In terms of pesticides, an organochlorine compound, 
referred to as DDT, is a well-known example of a known carcinogenic pesticide. DDT 
came out in the 1930s, and it was initially used in military operations in World War II 
because it was extremely important in the control of malaria, as well as the protection of 
soldiers against acquiring malaria (Carson, 1962). Its toxicity was only really appreciated 
in response to a text by Rachel Carson entitled Silent Spring, which heightened public’s 
awareness of the fact that DDT had a long persistence in the environment. Eventually, 
DDT was utilized as an insecticide because it had the ability to activate sodium channels 
in insects, resulting in the paralysis and eventual death of the insects. DDT was 
eventually banned from use in the US (Carson, 1962). In terms of carcinogenic aromatic 
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hydrocarbons, benzene and benzopyrene are two examples of aromatic hydrocarbons that 
have been implicated in increasing one’s risk for leukemia and lung cancer, respectively 
(Murray et al., 2012). These hydrocarbons act by oxidizing either cytochrome P450 
enzymes and/or epoxide hydrolase leading to the generation of mutagenic metabolites. 
Finally, in terms of metal compounds, compounds such as beryllium and nickel 
subsulfide have been implicated in causing a variety of different types of cancers, most 
notably, lung cancer. Substances, such as the ones listed above, are tested for 
carcinogenicity through the Ames Test, which is a powerful tool in testing the mutagenic 
potential of chemicals.  
 Based on data collected by the National Cancer Institute (2011), in the United States, 
there will be an estimated 1,665,540 new cases of cancer in 2014, as well as an estimated 
585,720 deaths as a result of cancer. In 2011, the Nation Cancer Institute found that 
approximately 13,397,159 people were living with cancer in the United States. Moreover, 
for both males and females, it is approximated that 40.8 percent of people will be 
diagnosed with cancer within their lifetime (National Cancer Institute [NIH], 2011). 
Currently, cancer is the second leading cause of death within the United States, behind 
heart disease, but it is predicted that cancer will become the predominant form of 
mortality in the US within the next 15 years. The median age of cancer diagnosis is 66 
years old, while the median age of mortality as a result of cancer is 72 years old. Males 
have a higher incidence of cancer as compared to females. Furthermore, African 
Americans, Non-Hispanics, and Caucasians have both the highest incidence of cancer 
amongst ethnic groups, as well as the highest incidence of mortality from cancer amongst 
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ethnic groups (NIH, 2011). Cancer incidence in the United States has taken center stage 
within the media in recent years, with many scientific researchers focusing their research 
on discovering innovative methods to both diagnose, as well as treat certain types of 
cancers. Figure 3 demonstrates the trends in both the incidence and mortality of cancer 
within the United States over the last thirty years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Trends in Cancer Incidence and Mortality in the United States between 
1975 and 2010. Incidence of cancer has remained relatively steady from 1975 to 2010, 
except for a spike in incidence in the early 1990s. Cancer mortality has decreased from 
1975 to 2010. Figure taken from Siegel et al., 2014. 
 
Chemotherapy Treatment for Cancer Patients 
 Presently, the golden standard of treatment for individuals afflicted with locally 
advancer cancer is adjuvant chemotherapy treatment. Adjuvant chemotherapy treatment 
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is basically a combined therapeutic approach, consisting of radiation therapy and/or 
surgery, and then subsequent chemotherapy treatment (Chu & Sartorelli, 2012). Adjuvant 
chemotherapy is utilized in patients in order to both decrease the likelihood of cancer 
recurrence, as well increase a patient’s overall survival. However, chemotherapy 
treatment can also be utilized as the primary method of treatment in some patients where 
the cancer has metastasized and no other methods of treatment are effective, or it can be 
utilized in patients who have localized cancer, but alternative treatments are not 
completely efficacious in eradicating the cancer. Utilizing these standardized methods of 
treatment, it has been estimated that 50% of patients initially diagnosed with cancer will 
be cured (Chu & Sartorelli, 2012). Furthermore, chemotherapy treatment has a much 
higher cure rate when combined with surgery and/or radiation therapy, as compared to 
when it is utilized as the primary method of treatment (Chu & Sartorelli, 2012). 
 Several chemotherapeutic agents exist today, and the type of chemotherapeutic agent 
utilized for treatment is dependent on the type and stage of cancer a person has. Types of 
anticancer agents include: cytotoxic drugs, hormones and antagonists, monoclonal 
antibodies, and anti-angiogenic agents.	  Cytotoxic drugs are drugs that will kill any cell, 
and were the first anticancer agents discovered. Antimetabolites, alkylating agents, 
antibiotics, such as topoisomerase inhibitors, and plant alkaloids, such as microtubule 
inhibitors are the four classes of cytotoxic drugs. Antimetabolites were discovered in the 
1950s and they are drugs that block the synthesis of purines and pyrimidines. Alkylating 
agents are drugs that are highly chemically reactive and are capable of alkylating DNA, 
most commonly at the N7 position of guanine, eventually resulting in cell death. 
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Topoisomerase inhibitors act on the coiling and uncoiling of DNA, and effectively inhibit 
cell replication. Microtubule inhibitors are agents that interfere with the actions of 
microtubules and thus block mitosis, ultimately preventing cell division. Examples of the 
four types of cytotoxic drugs are listed in Table 2, along with their respective 
mechanisms of action, as well as their adverse side effects. In terms of hormones and 
antagonists, there exists tumor cells that are hormone dependent, and thus strategies have 
been developed in order to block endogenous hormones and prevent the development of 
tumors (Chu & Sartorelli, 2012). In terms of monoclonal antibodies, there are drugs that 
act by specifically targeting a site on a protein of a cancer cell, effectively destroying that 
cell. Lastly, anti-angiogenic agents are drugs that act on a protein critical in solid tumors 
for promoting the development of blood vessels within the tumor. By preventing the 
development of new blood vessels, tumors are unable to retrieve the proper nutrients 
needed for replication, and thus cell replication is inhibited. 
 Within the clinical setting, oncologists commonly implement chemotherapy 
regimens in order to treat a patient diagnosed with cancer.	  Standard chemotherapy 
treatment protocols, such as ABVD, are common in identifying combinations of drugs 
used for treatment in cancer chemotherapy. The goal of combination chemotherapy 
treatment is to put together drugs with differing target sites, thus improving the efficacy 
of the treatment, as well as lowering the toxicity of the treatment, ultimately improving 
the therapeutic index of the treatment. The utilization of several chemotherapeutic agents 
is also imperative in slowing the development of drug resistance, further increasing the 
effectiveness of the drug regimen. Selection of specific chemotherapeutic regimens is 
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based on five principles: efficacy, toxicity, optimum scheduling, mechanism of 
interaction, and avoidance of arbitrary dose changes (Chu & Sartorelli, 2012). An 
effective drug is a drug that has high efficaciousness, low toxicity, is utilized at its most 
advantageous dose and schedule, is well understood mechanistically, and does not need a 
reduction in dosage in order to incorporate another drug into the regimen.  
 Upon careful selection of an effective drug regimen, the main limitation that 
prevents chemotherapeutic agents from achieving cure is dose intensity (Chu & 
Sartorelli, 2012). Due to the fact that many chemotherapeutic agents are highly toxic, and 
can result in several adverse effects, it is common practice for clinicians to alter the dose 
or the dosing regimen in order to reduce the toxicity side effects. However, because the 
therapeutic window for chemotherapeutic agents is extremely sensitive, as evidenced by 
animal model studies, a slight reduction in dosage could potentially eliminate the 
therapeutic effect of the chemotherapeutic agent (Chu & Sartorelli, 2012). In order to 
avoid the loss of a chemotherapeutic regimen’s efficacy, clinicians implement three 
specific strategies: drug escalation, reducing the interval, and sequential scheduling (Chu 
& Sartorelli, 2012). Drug escalation deals with escalating the doses of the 
chemotherapeutic agents. Reducing the interval is associated with decreasing the amount 
of time between treatment cycles. Sequential scheduling is associated with chronological 
administration of single chemotherapeutic agents or of chemotherapeutic regimens. 
Though these strategies have proven to be effective in improving clinical outcomes, the 
strategies also lead to exacerbation of adverse side effects, due to the fact that the 
strategies are quite aggressive. 
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 The types of adverse side effects that cancer patients experience as a result of 
chemotherapy treatment is dependent on the chemotherapeutic agent that is utilized for 
treatment. For example, cisplatin, which is a platinum analog chemotherapeutic agent that 
has a similar mechanism of action as compared to alkylating agents, is used to treat 
several types of cancer, including lung cancer, and it causes a vast array of side effects 
ranging from nausea and vomiting to nephrotoxicity, peripheral sensory neuropathy, 
ototoxicity, and nerve dysfunction (Chu & Sartorelli, 2012). However, nearly all-
chemotherapeutic agents utilized to destroy neoplastic cells result in nausea, vomiting, 
myelosuppression, fatigue, and depression. A common feature of many cancer 
chemotherapeutics is that they are emetics; the chemotherapeutic drugs activate 5HT3 
receptors within the GI tract, which results in excitation of neurons, eventually leading to 
the induction of nausea and vomiting (Sharkey & Wallace, 2011). Chemotherapeutic 
agents also are toxic to the bone marrow of patients, resulting in bone marrow 
suppression, and a subsequent reduction in the creation of leukocytes, erythrocytes, and 
thrombocytes, which are cells that play important roles in immunity, oxygen transport, 
and blood clotting, respectively. Furthermore, fatigue and depression side effects develop 
in many cancer patients as a result of the nausea, vomiting, myelosuppression, and 
aggressive nature associated with the chemotherapeutic treatment.  
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Table 2. Examples of Common Cytotoxic Drugs used as Chemotherapeutic Agents. 
Table modified from Lange: Basic & Clinical Pharmacology, 12th edition, 2012. 
 
Type of 
Chemotherapeutic 
Drug 
Generic Name of 
Drug 
Mechanism of 
Action 
Adverse Effects 
Alkylating Agent  Cisplatin Forms intrastrand and 
interstrand DNA cross-
links; binding to nuclear 
and cytoplasmic 
proteins 
Nausea, vomiting, 
nephrotoxicity, 
peripheral sensory 
neuropathy, 
ototoxicity, nerve 
dysfunction 
Antimetabolite  Methotrexate Inhibits Dihydrofolate 
reductase, inhibits 
thymidine synthase, 
inhibits de novo purine 
nucleotide synthesis 
Mucositis, diarrhea, 
myelsuppression with 
neutropenia and 
thromocytopenia 
Antibiotics  Etoposide Inhibits topoisomerase 
II 
Nausea, vomiting, 
hypotension, alopecia, 
myelosuppression 
Plant Alkaloids  Docetaxol Inhibits mitosis hypersensitivity, 
neurotoxicity, fluid 
retention, 
myelosuppression with 
neutropenia 
 
Introduction of Palliative Care 
  
 Though chemotherapeutic agents are associated with several debilitating side effects, 
modern medicine has made it possible to alleviate many of those negative side effects 
through palliative care. In the early 1950s, medical experts were more focused on finding 
a cure for patients suffering from cancer, as opposed to both treating the patient’s illness, 
as well as the side effects that were associated with the treatment of the illness (Clark, 
2007). In the 1960s, Cicely Saunders, a research fellow at St. Joseph’s Hospice in 
Hackney, London, UK, began interviewing patients about their personal experiences 
while combating a terminal illness. What soon emerged from her research was a striking 
pattern of patients reporting extensive physical and mental suffering as a result of the 
terminal illness. Saunders soon began to push for clinicians to prescribe analgesic agents 
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in order to help prevent the constant pain that the many patients suffering from terminal 
diseases felt. At the same time that palliative care began to emerge as a common clinical 
practice, President Richard Nixon, who declared a “war on cancer” in 1971, thrust cancer 
into the forefront of the public eye. Soon, in 1982, the World Health Organization 
enlisted palliative care experts in order to help develop a standardized method for cancer 
pain relief. Though the attempt by the WHO to develop a program for cancer pain relief 
was relatively unsuccessful, the WHO managed to initiate the integration of palliative 
care into oncological curative treatment programs.  
 Today, palliative care is an integral part of the treatment plan for cancer patients, and 
those suffering from terminal illnesses. Figure 4 shows how palliative care has been 
growing steadily within US hospitals. However, as Gaertner et al. (2014) found, there 
still remains ambiguity in terms of what the specific aims of palliative care are, and it is 
essential for organizations such as the WHO to clearly define the goals of palliative care. 
Moreover, Aaist-Cohen et al. (2008) conducted a survey on 37% of medical schools 
within the United States assessing the extent and manner that palliative care is 
incorporated in the United States medical school curriculum. These authors found that 
30% of responding schools included palliative care within their curriculum, 19% included 
palliative care as a rotation, 15% offered palliative care as an elective course, 29% 
offered palliative care as an elective rotation, and 53% of schools integrated palliative 
care into required courses. These results demonstrate that medical schools in the United 
States have not fully educatied future physicians on palliative care, and thus there is a 
need for greater attention to provide palliative care education to future healthcare 
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professionals in order for palliative care to be properly administered to patients when 
needed. 
 
Figure 4. Prevalence of U.S. Hospital Palliative Care Teams between 2000 – 2009. 
The number of hospitals with palliative care teams has been increasing since 2000. Figure 
modified from CAPC Report Card, 2011. 
 
 Though palliative care is still a growing field, there still are several medicinal 
approaches that palliative care specialists utilize in order to alleviate some of the side 
effects associated with cancer treatment. For example, patients undergoing chemotherapy 
treatment are commonly prescribed anti-emetics, which act as 5HT3 receptor antagonists, 
and subsequently prevent the nausea and vomiting that coincides with chemotherapy 
treatment (Sharkey & Wallace, 2011). Also, in order to treat the myelosuppression that 
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many cancer patients experience, physicians administer growth factors for cells made in 
the bone marrow, such as GM-CSF for neutrophils or erythropoietin for red blood cells, 
which stimulate replication of precursor cells in the bone marrow (Yuen & Giralt, 2011). 
Furthermore, depressive side effects are commonly treated with anti-depressive agents, 
such as Prozac, which is a selective serotonin reuptake inhibitor (DeBattista, 2012). 
However, in terms of fatigue, there are currently no proven medicinal treatments that 
effectively alleviate fatigue in cancer patients. Peuckmann-Post et al. (1996) found that 
even though several drugs exist on the market that have the potential to improve fatigue 
in patients, such as amantadine and methylphenidate, there is no full consensus within the 
medical field as to which drugs should be utilized to treat fatigue. There are, however, 
several non-medicinal approaches currently being investigated by scientific researchers 
that have shown promising results in improving the quality of life of cancer patients.  
Positive Effects of Exercise, Music, and Spirituality 
 Three of the most common non-medicinal approaches that patients have cited as 
being helpful in improving their quality of life are exercise, music, and 
spirituality/religion (Chalise et al., 2012). The positive aspects of exercise on improving 
quality of life and preventing disease have been extensively studied for many years. In 
1996, Dr. Elrick, a medical doctor with an extensive background in understanding the 
positive effects of exercise, wrote an article concerning how physicians can prescribe 
exercise therapy in order to treat diseases (Erlick, 1996). In terms of cardiovascular 
health, exercise could be utilized in order to improve heart function, as well as reduce 
hypertension, cholesterol levels, and low-density lipoprotein levels (Erlick, 1996). 
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Moreover, Erlick found that exercise could be utilized to combat both diabetes and 
obesity. Daily exercise can help reduce weight in obese individuals, as well as both 
correct abnormal blood lipid patterns that have been implicated in diabetes, and increase 
an individual’s sensitivity to insulin by increasing sugar metabolism within that 
individual (Erlick, 1996). Exercise has also been cited as a potential therapy for 
cerebrovascular disease, arthritis, osteoporosis, dyslipidemia, depression, cancer, and 
COPD (Erlick, 1996). 
 In terms of music, the positive affects that music offers have been utilized for 
centuries, dating back all the way to ancient Greece. The true advent of music as a tool 
for therapy emerged following both World War I and II, when musicians would visit 
hospitals to play music for the wounded soldiers (“Music Therapy,” 2014). Today, there 
is much research concerned with the potential positive benefits that music offers in order 
to help treat certain disease states. For example, in children, music therapy has been 
utilized in autism patients to help improve various social deficits that these patients face 
(Crowe & Colwell, 2007). Moreover, music has strong implications on the lives of 
adolescents, particularly in helping adolescents achieve a sense of identity, cope with 
tough situations, and develop a sense of independence (Laiho, 2004). Most notably, 
music therapy has been utilized in an array of neurological and psychological disorders. 
For example, a study conducted by Nayak et al. (2000) found that music therapy could 
potentially be utilized as a supplemental therapy for patients who suffered a stroke in 
order to improve social functioning and participation in rehabilitation. Music therapy has 
also been indicated in depression. Chan et al. (2009) found that music therapy in patients 
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suffering from depression, led to decreases in both depressive scores and blood pressure 
in those patients. 
 Lastly, spirituality, similar to music therapy, has also been a source of healing for 
centuries. For example, in ancient Greece, society members prayed to Asclepius, known 
as the Divine Physician, in order to help heal wounded or diseased individuals. A study 
conducted by Rew and Wong (2006) discovered that spirituality might potentially be an 
important factor in improving adolescent health and behavior. Furthermore, a second 
study conducted by Bonelli and Koenig (2013) found further positive correlation between 
spirituality and improvement in mental health in the areas of depression, substance abuse, 
suicide, stress-related disorders, and dementia. However, the extent that spirituality 
provides a positive influence has not been completely corroborated by research studies. 
The main limitation that prevents attainment of conclusive data on spirituality and its 
effects on improving disease states is the fact that individuals have differing levels of 
spirituality. However, current research is beginning to focus on figuring out potential 
ways to utilize an individual’s spirituality as a source of healing within the clinical 
setting. For example, one paper published by Moreira-Almeida et al. (2014) provided 
guidelines for assessing a patient’s spirituality, and subsequently utilizing a patient’s 
spirituality in order to help treat their disease. 
Exercise, Music, and Spirituality as Resources for Palliative Care in Cancer Patients 
 The role of exercise as a therapy for cancer patients is particularly intriguing. Early 
epidemiological evidence has suggested that physical training can protect against certain 
types of cancers. In one prospective study conducted by Holmes et al. (2005) on 
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approximately 3000 females diagnosed with stage 1, 2 or 3 breast cancer, it was found 
that women who walked the equivalent of 3 to 5 hours a week reduced their risk of death 
from the disease. These results are further supported by data published by Segal et al. 
(2001), which found that 6 months of aerobic training resulted in improvement in both 
fitness and physical functioning in patients with Breast Cancer. Though exercise has 
proven positive effects on patients afflicted with cancer, up until recently, studies have 
been too broad on researching the particular aspects that exercise helps to improve in 
patients with cancer. Current studies are now focusing on how exercise can be integrated 
before, during, and after chemotherapy treatment in order to improve both fatigue and 
quality of life in cancer patients. It is imperative that researchers focus on establishing a 
method to train physicians on how to successfully integrate a personalized physical 
training method for patients undergoing a chemotherapy regimen in order to optimize the 
effects that exercise has to offer for cancer patients.  
 Music therapy is a second resource that can be utilized as a palliative care option to 
treat the side effects associated with chemotherapy treatment. Music therapy has been 
utilized in the clinical setting as a tool for palliative care, and it has demonstrated positive 
results. In a study conducted by Gutgsell et al. (2013) where 200 patients were randomly 
assigned to either receive standard care or standard care with music therapy, it was found 
that there was a significant reduction in pain scores for patients who had their care 
supplemented with music therapy. Though music therapy has demonstrated positive 
results in helping patients, there still remains a lack of sufficient studies to determine the 
true efficacy of music therapy, especially music therapy utilized to improve the quality of 
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life of cancer patients. Korczak et al. (2013) conducted an analysis of the current 
literature concerned with the use of music therapy for palliative care, and they discovered 
conflicting results. They concluded that there is a need for higher quality studies on 
music therapy in order to understand the true effects that music therapy offers to patients. 
Though research on music therapy for cancer patients undergoing chemotherapy 
treatment has been lacking in the past, recently, there has been a push to determine the 
efficacy of music therapy in improving the quality of life of cancer patients. 
 One last resource that can be utilized in palliative care for cancer patients undergoing 
chemotherapy treatment is spirituality. As stated previously, the efficacy of spirituality in 
palliative care is not completely understood. It has been documented that spirituality aids 
patients in finding meaning in their suffering. Dr. Puchalski (2012), researching the role 
of spirituality in health care, found that spirituality helps patients with mortality, coping, 
and recovery. It has been proposed that spirituality possibly increases lifespan through 
improving stress control (Puchalski, 2012). In terms of coping, one cited study reported 
that 93% of 108 women claimed that spirituality was a significant factor in helping them 
cope with gynecological cancer. Interestingly, it was found that 49% of those patients had 
become more spiritual after their diagnosis (Puchalski, 2012). Furthermore, Young et al. 
(2014) found that patients who had undergone a significant cardiac event, also found 
spirituality to provide greater meaning and purpose in their lives, and led to an easier 
transition in coping with their life-threatening illness. Thus, cancer appears to lead more 
people to lean on spirituality as a source for coping with their illness, and spirituality can 
therefore be utilized as an effective tool to improve patients’ quality of life. Specifically, 
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spirituality has the ability to improve the quality of life of patients undergoing 
chemotherapy treatment. 
 The positive influences that exercise, music therapy, and spirituality have on 
improving disease state are well published within the literature. In particular, the positive 
aspects that exercise offers to patients are well corroborated by published data. The 
positive effects that both music therapy and spirituality offer are encouraging, but further 
research is needed in order to definitively determine that music therapy and spirituality 
should be utilized within the clinic in order to help improve patient outcomes. However, 
exercise, music therapy, and spirituality all have the ability to be excellent palliative care 
resources for cancer patients undergoing chemotherapy treatment. Exercise can be 
utilized to improve fatigue in cancer patients, and both music therapy and spirituality can 
be utilized to improve the depressive side effects associated with chemotherapy 
treatment. 
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Specific Aims/Objectives 
 Previous studies have demonstrated that alternative treatments, such as exercise 
and listening to music, are effective treatments for improving fatigue, anxiety, and 
depression, which are side effects associated with chemotherapy treatment. However, 
there has not been significant scientific research that has focused on developing specific 
methods on how to successfully integrate these alternative therapies into the lives of 
patients undergoing chemotherapy treatment. Specifically, 
1. The effectiveness of exercise, music therapy, and spirituality before, during, and 
after chemotherapy treatment in cancer patients will be examined. 
2. The ability for exercise, music therapy, and spirituality to lower fatigue and 
depression in patients will be examined. 
3. The efficacy of certain types of exercises and certain types of music to improve 
fatigue and depression in cancer patients undergoing chemotherapy will be 
determined. 
It is hypothesized that fatigue and depression scores in cancer patients undergoing 
chemotherapy treatment will significantly decrease while exercising and listening to 
music before, during, and after chemotherapy treatment, with the most significant 
improvement displayed after chemotherapy treatment. The efficacy of spirituality will 
most probably be dependent on how spiritual a patient is during chemotherapy treatment, 
so fatigue and depression scores will most likely vary. These results can provide insight 
into potentially new strategies for combating several of the negative side effects 
associated with chemotherapy treatment.
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 PUBLISHED STUDIES  
 Before discussing the efficacy of exercise, music therapy, and spirituality in 
treating patients suffering from the adverse side effects of chemotherapy treatment, it is 
imperative to determine how the adverse side effects of cancer treatment affect the lives 
of cancer patients. Li et al.  (2014) conducted a study where they determined how 
chemotherapy treatment affected the health-related quality of life of Chinese elderly 
patients with advanced cancer. The study surveyed 109 elderly patients, who were 60 
years of age or older, being treated for advanced cancer with chemotherapy treatment (Li 
et al., 2014). The survey utilized assessed the HRQOL, anxiety, and depression of the 
cancer patients (Li et al., 2014). HRQOL was evaluated through the Medical Outcomes 
36-Item Short Form Health Survey, as well as the European Organization for Research 
and Treatment of Cancer, quality of life questionnaire (Li et al., 2014). Both surveys 
assessed general health, physical functioning, role functioning, emotional health, 
cognitive functioning, social functioning, and adverse side effects associated with 
chemotherapy treatment, such as fatigue and pain (Li et al., 2014). Anxiety and 
depression in the cancer patients was assessed through the Hospital Anxiety and 
Depression Scale (Li et al., 2014). It was found that both financial impact and fatigue 
were the most significant factors associated with chemotherapy treatment, as reported by 
patients. Moreover, anxiety and depression had a strong impact on HRQOL (Li et al., 
2014). However, this study may not be completely generalizable to all cancer patients 
since the study only looked at elderly patients with advanced cancer. 
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 Ancoli-Israel et al. (2014) conducted a similar study that assessed the quality of 
life of breast cancer patients both before and after chemotherapy treatment. The study 
enrolled 68 women with stage 1 to stage 3 breast cancer, who were to undergo greater 
than or equal to four treatments of chemotherapy (Ancoli-Israel et al., 2014). The study 
matched participants with 60 controls who were cancer-free based on age, ethnicity, and 
education. Three different scales were assessed: sleep, fatigue, and depression. Sleep was 
analyzed using both actigraphy and the Pittsburgh Sleep Quality Index, which assessed 
both nocturnal total sleep time and daytime total naptime. Fatigue was measured through 
the Fatigue Symptom Inventory-Short Form. Lastly, the researchers measured depression 
through the Center of Epidemiological Studies-Depression. The study participants were 
evaluated before chemotherapy treatment, at the end of the fourth cycle of chemotherapy 
treatment, and then 1 year post-chemotherapy (Ancoli-Israel et al., 2014). It was found 
that compared to controls, patients with breast cancer displayed worse sleep quality, 
greater fatigue, increased depressive symptoms, increased disrupted circadian rhythms, 
and worse quality of life at baseline. When patients were evaluated at the fourth cycle of 
chemotherapy treatment, the cancer patients all displayed worse ratings for all factors 
assessed as compared to baseline (Ancoli-Israel et al., 2014). One year after 
chemotherapy treatment, fatigue, depression, and quality of life levels for breast cancer 
patients all returned to baseline, but the levels were still worse as compared to controls 
(Ancoli-Israel et al., 2014). Figure 5 shows the changes in sleep, fatigue, and depressive 
symptoms that breast cancer patients experienced as a result of chemotherapy treatment. 
The study conducted by Ancoli-Israel et al. (2014) was still limited in terms of its 
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generalizability due to the fact that the participants were only females with stage 1 to 
stage 3 breast cancer from a single geographic region. The results provide some evidence 
for the need to address the side effects associated with both cancer and chemotherapy 
treatment, but broader studies are needed for more definitive proof. 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Changes in Sleep (a), Fatigue (b), & Depressive Symptoms (c) as a Result 
of Chemotherapy Treatment for Breast Cancer Patients (BC) as Compared to 
Cancer-free Controls (NC). Sleep, fatigue, and depressive symptoms all worsen as 
compared to baseline after cycle 4 of chemotherapy treatment for breast cancer patients. 
Figure taken from Ancoli-Israel et al., 2014. 
 
To determine how debilitating chemotherapy treatment was to cancer patients, 
Wang et al. (2014) conducted a study that aimed to discover the extent of how severe 
fatigue was to cancer patients. They enrolled 3123 patients who suffered from breast, 
	  27 
prostate, colorectal, or lung cancer, and were either undergoing chemotherapy treatment 
or were following up with a physician at an outpatient setting. Fatigue was measured 
using the M.D. Anderson Symptom Inventory, which rated fatigue on a scale of zero to 
ten, with zero representing no fatigue, and ten representing severe fatigue. Study 
participants also were asked to rate their overall quality of life as excellent, good, fair, 
poor, or very poor. Wang et al. (2014) found that for the 2177 patients actively 
undergoing treatment, 55% responded to having no or mild fatigue and 45% responded to 
having moderate to severe fatigue. The authors also found that for the 515 patients 
labeled as cancer survivors, and not undergoing cancer treatment, 71% responded to 
having no or mild fatigue and 29% responded to having moderate to severe fatigue. In 
terms of type of cancer, Wang et al. (2014) found that fatigue affected patients regardless 
of the specific type of cancer the patients had. Due to the fact that fatigue has large 
implications on the daily activity of patients undergoing chemotherapy treatment, the 
study demonstrates a strong need for clinicians to have the necessary tools to assess and 
evaluate the extent of fatigue in cancer patients. Moreover, the study also substantiates 
the need for finding effective treatments for subsiding fatigue in cancer patients in order 
to improve the quality of life of such patients. The main limitation for this study was the 
fact that the scale used to rate fatigue was objective in nature, and a more subjective 
rating system would be needed in order to determine the actual extent of fatigue in cancer 
patients (Wang et al., 2014). However, the study still illustrates a need to both assess and 
treat the adverse effects associated with cancer treatment due to the fact that there was a 
high prevalence of moderate to severe fatigue in cancer patients undergoing treatment. 
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 To demonstrate a need for managing fatigue and pain associated with 
chemotherapy treatment, Ediebah et al. (2014) analyzed data from a lung cancer trial 
study that had enrolled 391 patients afflicted with non-small-cell lung cancer in order to 
compare chemotherapy regimens. Patients in this lung cancer trial had advanced stage 
non-small-cell lung cancer, and were between the ages of 18 and 76. Patients were 
administered different regimens of chemotherapeutic drugs every 3 weeks. The 
chemotherapeutic drugs that were utilized in the trial were paclitaxel, cisplatin, and 
gemcitabine. Health-related quality of life was recorded in the patients through the 
EORTC QLQ-C30 and QLQ-LC13, which are questionnaires that assess the quality of 
life in the generalizable cancer population and also the lung cancer population, 
respectively. Higher scores in the questionnaire represented an increased functioning 
level. Patients were assessed pretreatment, as well as following each chemotherapy 
regimen (Ediebah et al., 2014). It was found that every 10-point increase from baseline 
levels in pain and dysphagia was correlated with an 11% and 12% greater risk of death, 
respectively. Moreover, a 10-point increase in physical function from baseline was 
associated with a 7% decrease in mortality (Ediebah et al., 2014). For specific 
chemotherapy cycles, a 10-point increase in pain in cycle 1 was positively correlated with 
an 8% increased mortality risk, and every 10-point increase in social function in cycle 2 
decreased the risk of mortality by 9%. Thus, the study demonstrated that the pain and 
fatigue associated with chemotherapy treatment could lead to decreased survival rates in 
cancer patients. Though this study was limited by the fact that it only looked at cancer 
patients with stage 3 or stage 4 non-small-cell lung cancer, their findings still lend 
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significant credence to the fact that clinicians should focus on improving the quality of 
life of patients during chemotherapy treatment, in order to help increase survival in such 
patients. 
 Andersen et al. (2013) carried out a study where the relationship between exercise 
and cancer-related fatigue was analyzed. The goal of their study was to determine the 
efficacy of exercise as an adjunct to chemotherapy treatment (Andersen et al., 2013). The 
researchers utilized data collected from a prospective randomized control trial known as 
“The Body & Cancer Trial” (Andersen et al., 2013). The trial enrolled 213 cancer 
patients with varying types of cancers currently undergoing chemotherapy treatment, and 
subsequently divided those patients into either a treatment group or control group. 
Investigators determined a patient’s fatigue level through the Functional Assessment of 
Cancer Therapy-Anaemia Questionnaire. The training regimen for the treatment group 
took place over the course of 6 weeks, 9 hours per week, and in the morning hours. The 
training regimen was comprised of “high-intensity cardiovascular workouts, relaxation 
training, body-awareness training, and massage” (Andersen et al., 2013). Following the 
6-week training regimen, the treatment group showed significantly lower fatigue scores 
as compared to the control group. However, no statistically significant effect of exercise 
on quality of life, as well as physical, emotional, social, and function scores was found. 
Table 3, below, illustrates the effect of a 6-week exercise intervention as an adjunct to 
chemotherapy treatment on several different parameters, such as fatigue and quality of 
life. The main limitation of the study was the fact that many of the participants in the 
study showed increased motivation to participate, and most participants were younger 
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and better educated as compared to the general population (Andersen et al., 2013). This 
limitation, as well as the fact that exercise showed no significant improvement in the 
quality of life of patients proves that further studies are needed in order to gain a better 
understanding on the full range of beneficial effects that exercise offers to patients 
undergoing chemotherapy treatment. 
Table 3. Changes in Fatigue, FACT-An score, FACT-G score, FACT-An Toi score, 
ANS Score, Physical Function, Emotional Function, Social Function, & Quality of 
Life after 6-week Exercise Intervention. Fatigue, FACT-An score, FACT-An Toi 
score, and ANS score all show statistically significant improvements as compared to 
baseline after 6-week exercise intervention. Table modified from Andersen et al., 2013. 
 
 
 
  
 
 
 
 
 
 
 
 
A study conducted by Jacobsen et al. (2013) investigated the efficacy of both 
exercise and stress-management training in improving the quality of life of cancer 
patients. Investigators first assessed each patients bodily functioning, psychological 
functioning, anxiety levels, depression levels, exercise regimens, and stress reduction 
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behavior (Jacobsen et al., 2013). Participants were then randomized into four groups: 
“stress-management intervention, exercise intervention, combined stress-management 
and exercise intervention, or control group” (Jacobsen et al., 2013). Of the 460 
participants who were enrolled in the study, 286 participants completed the study. 
Intervention treatments were administered concurrently with chemotherapy treatment, 
and the patients were evaluated at both 6 and 12 weeks after chemotherapy started. The 
150 patients that did not complete the study were found to have an increased likelihood 
of having received both chemotherapy and radiotherapy treatment (Jacobsen et al., 2013). 
The participants of the study were mainly female, white, and non-Hispanic. Moreover, 
the majority of participants were diagnosed with either breast or lung cancer. Researchers 
utilized several different scales to assess the quality of life of cancer patients who 
completed the study. It was found that combined stress-management and exercise 
intervention led to increased overall quality of life in patients, as compared to patients 
who were only administered standard care. Moreover, coinciding with the findings of 
Andersen et al., this study found that exercise or stress-management alone did not lead to 
substantial changes in quality of life (Andersen et al., 2013, Jacobsen et al., 2013). The 
study conducted by Jacobsen et al. had several limitations. The main limitation was the 
high attrition rate, but investigators cited the fact that patients with lower baseline 
physical functioning levels due to combined chemotherapy and radiotherapy treatment 
were the main participants to not complete the study (Jacobsen et al., 2013). Also, 
participants in the study were not supervised in order to ensure that they adhered to the 
interventions they were designated to undergo (Jacobsen et al., 2013). Lastly, the effect 
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that combined stress-management and exercise had on quality of life was relatively small, 
but the authors explained that the study was conducted within a limited timeframe, and 
with inadequate resources, suggesting that increased intervention time may lead to a 
greater effect on quality of life. Overall, the study by Jacobsen et al., along with the study 
by Andersen et al. demonstrate the potential for exercise and stress-management 
intervention in improving fatigue and quality of life in cancer patients, but larger trials 
are needed to fully determine the efficacy of the interventions (Andersen et al., 2013; 
Jacobsen et al., 2013). 
 In order to get a better representation of the effects of exercise intervention on 
cancer patients undergoing chemotherapy treatment, Mishra et al. (2012) conducted a 
meta-analysis that integrated 56 different clinical trials encompassing 4826 patients. 2286 
of those patients received exercise intervention, and 1985 of the 4826 patients were part 
of the control group. 36 of the 56 trials were conducted while patients were undergoing 
chemotherapy treatment. 10 of the 56 trials were conducted while patients were 
undergoing chemotherapy treatment, as well as post-treatment. The remaining 10 trials 
were conducted before patients were to begin a chemotherapy regimen. The types of 
exercises utilized in each of the trials, the types of cancers the patients were diagnosed 
with, and the types of scales utilized to measure health-related quality of life all varied 
between trials. Researchers concluded that “exercise intervention resulted in 
improvements in health-related quality of life, physical functioning, role functioning, 
social functioning, and fatigue” (Mishra et al., 2012). Researchers also discovered that 
breast cancer patients saw a greater reduction in anxiety as compared to other types of 
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cancers. Moreover, patients with cancers other than breast cancer experienced a greater 
reduction in depression, fatigue, and sleep disturbances, as well as greater enhancement 
in health-related quality of life, emotional well being, bodily functioning, and role 
function (Mishra et al., 2012). In terms of the training regimen that was most effective, 
investigators found that a moderate/vigorous exercise routine resulted in better outcomes 
as compared to a mild exercise routine. The researchers noted that all the trials might 
have been influenced by performance and selection bias. Moreover, the researchers noted 
that most of the trials might have been limited by detection and attrition.  
 Exercise intervention has proven efficacy in reducing fatigue, yet its effect on 
improving quality of life has not been fully determined. Music therapy is an alternative 
non-medicinal approach that has been studied in order to determine its efficacy in 
improving quality of life, anxiety, and depression in cancer patients undergoing 
chemotherapy treatment. One study by O’Callaghan et al. (2012) delved into determining 
the effects of music-based therapy on cancer patients. The study focused on young 
adolescents afflicted with cancer due to the fact that music listening is a widespread 
phenomenon amongst teenagers, with “adolescents listening to or watching music for an 
estimated 56.6 hours per week” (O’Callaghan et al., 2012). The study enrolled 12 
adolescents between the ages of 15 and 25 years old. Investigators collected data on the 
effects of music therapy on improving quality of life of cancer patients through both a 
music demographic questionnaire, as well as an interview session (O’Callaghan et al., 
2012). The study participants mainly cited music as having a soothing, caring, and 
relaxing effect, which helped in subsiding suffering associated with cancer diagnoses. 
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The study participants also reported that music listening helped in enduring both the 
cancer treatment phase, as well as the post-treatment phase (O’Callaghan et al., 2012). 
The participants explained that music had the ability to express messages, as well as aid 
in dealing with emotional responses. In terms of having sessions with music therapists, 
participants were divided. Some of the participants sought out music therapists and cited 
them as a viable option to help with symptom reduction strategies, while other 
participants felt the music therapy sessions were uncomfortable. Overall, investigators 
determined that music had the potential to “enable endurance, identity development, and 
adjustment while cancer patients were either undergoing treatment, or in the post-
treatment phase” (O’Callaghan et al., 2012). However, this study was limited due to its 
small sample size.. Moreover, the study could also potentially be affected by sources of 
bias.. While the study offers hopeful results for the integration of music therapy as an 
adjunct to chemotherapy treatment, larger, more detailed studies are needed in order to 
definitively determine music therapy’s role in the lives of cancer patients. 
 Lin et al., (2011) conducted one larger study looking into the efficacy of music 
therapy. The authors conducted a randomized control trial that enrolled 98 patients that 
were about to undergo chemotherapy treatment, and divided those patients amongst three 
different treatment interventions: 1 hour of music therapy treatment, 30 minutes of verbal 
relaxation treatment, and standard care. Investigators measured anxiety levels through the 
Chinese-STAI, which is a 40-item questionnaire that measures anxiety on a four-point 
scale (Lin et al., 2011). Immediate anxiety in cancer patients was measured through the 
Emotional Visual Analog Scale. The C-STAI was administered to participants before the 
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administration of cancer treatment, and the EVAS was administered after initiation of 
chemotherapy treatment. It was found that music therapy was more effective in reducing 
anxiety post-chemotherapy treatment as compared to either verbal relaxation treatment or 
standard care. Table 4 shows the changes in anxiety and EVAS scores following music 
therapy, verbal relaxation, or standard care treatment in cancer patients undergoing 
chemotherapy. Moreover, patients that were identified as having high state anxiety saw 
the greatest decrease in anxiety due to music therapy intervention as compared to patients 
identified as having normal state anxiety (Lin et al., 2011). It was also observed that 
music therapy utilized in cancer patients undergoing chemotherapy treatment led to a 
decrease in anxiety after thirty minutes of intervention. The main limitation of the study, 
as cited by the researchers, was the fact that the patients were not provided with their 
ideal type of music, even though previous studies had demonstrated that administration of 
preferred music resulted in better outcomes in patients (Lin et al., 2011). Though patients 
did not receive their preferred type of music, the study still resulted in anxiety reduction 
in patients. Thus, this study conducted by Lin et al. demonstrates that music therapy can 
be utilized as a potential tool to reduce anxiety in patients undergoing chemotherapy. 
Moreover, music therapy as an adjunct to chemotherapy treatment is potentially pertinent 
in both reducing anxiety in patients with high state anxiety, as well as in reducing anxiety 
in patients suffering acute anxiety symptoms post-chemotherapy treatment. 
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Table 4. Changes in Anxiety & EVAS Scores Before and After Music Therapy, 
Verbal Relaxation, or Standard Care. Anxiety and EVAS scores in cancer patients had 
greatest improvements following music therapy, as compared to verbal relaxation and 
standard care treatments. Figure modified from Lin et al., 2011. 
 
 
  
 
 
 
 
 
 
Similar to the study described above (Lin et al., 2011),  Romito et al. (2013) 
conducted a study on breast cancer patients that aimed to determine the effectiveness of 
music therapy intervention on reducing stress, anxiety, depression, and anger. The study 
enrolled 62 breast cancer patients receiving chemotherapy treatment. Half of the patients 
were placed in the experimental group, which received a 2.5-hour session of music 
therapy within a group format while undergoing chemotherapy treatment, while the other 
half of the patients were placed in the control group, which received the standard care. A 
patient’s stress, anxiety, depression, and anger was measured through the “Emotion 
Thermometers Tool,” which is an established oncologic tool utilized to measure the 
efficacy of a specific treatment, in this case music therapy (Romito et al., 2013). The 
authors found that patients who received music therapy intervention saw considerable 
reductions in stress, anxiety, depression, and anger levels. They also noted that anxiety 
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and stress were reduced in the control group after standard care treatment, but the effect 
size was negligible. Moreover, the perceived efficacy of treatment was greater in cancer 
patients receiving music therapy treatment versus the control group (Romito et al., 2013). 
One significant limitation of this study is that the music therapy intervention only 
consisted of one session. Another limitation of the study was that the sample size was 
relatively small. The limitations of this study elucidate the need for significantly larger, 
as well as lengthier well-controlled studies. However, the results concerning the effect of 
music therapy on anxiety still corroborate with the results discovered by Lin et al. (Lin et 
al., 2011; Romito et al., 2013). 
 As described above, several studies have produced results that demonstrate music 
therapy can potentially be an effective palliative care tool in the clinical setting in order 
to improve the quality of life of patients suffering from cancer and consequently 
undergoing chemotherapy treatment. Mesquita et al. (2013) conducted a study where they 
aimed to learn the role of spirituality/religion on people with cancer undergoing 
chemotherapy treatment. The study enrolled 101 patients undergoing chemotherapy 
treatment, 21 years and older. Data was collected during chemotherapy sessions and was 
assessed through the Brief-SRCOPE, which is a questionnaire that measures the extent 
that religious and spiritual strategies are utilized by patients in order to deal with difficult 
situations in life. The three main types of cancer amongst the study participants were 
colorectal, breast, and prostate cancer. Also, 37% of the study participants stated they had 
not experienced any adverse side effects of chemotherapy treatment, meanwhile 54% 
reported having mild to severe side effects from chemotherapy treatment (Mesquita et al., 
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2013). It was found that all 101 patients undergoing chemotherapy treatment reported 
that they had utilized spirituality for managing their side effects. Moreover, younger 
study participants, participants who reported having no religion, and participants that 
reported spirituality as being unimportant were more likely to utilize spiritual coping in a 
negative manner, meanwhile participants that were eager to utilize spiritual support and 
who actively participated in cancer support groups utilized spiritual coping in a positive 
manner (Mesquita et al., 2013). Furthermore, study participants that reported having 
severe side effects from chemotherapy treatment utilized spiritual coping to the greatest 
extent, as compared to the other study participants. However, when the side effects of 
chemotherapy treatment failed to subside, the patient tended to utilize negative coping 
strategies. The main limitation of this study was the fact that it took place in a single 
geographic area, and thus, the study results may not be completely generalizable to the 
general population (Mesquita et al., 2013). The authors concluded that spirituality can be 
potentially beneficial for patients suffering from the adverse side effects of chemotherapy 
treatment, but the benefit of spirituality appears to be reliant on the individual patients 
themselves.  
One common practice that many spiritual individuals undertake in order to 
establish a connection with their spirituality is yoga. Dhruva et al. (2012) conducted a 
study where they evaluated the effects of pranayama, or yoga breathing, on improving the 
side effects associated with chemotherapy treatment in cancer patients. Study participants 
were randomized into two different treatment groups: the pranayama group, which 
received pranayama while undergoing chemotherapy treatment, and the control group, 
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which received the standard care for chemotherapy treatment after the first cycle, and 
then received pranayama while undergoing chemotherapy treatment during the second 
cycle (Dhruva et al., 2012). A total of 16 study participants completed the study, and thus 
were utilized for the final analysis of the data. Fatigue, sleep disturbance, anxiety, 
depression, and stress were evaluated using a variety of clinically verified scales. 
Investigators collected data between the first and second cycles of chemotherapy, as well 
as after the completion of the study (Dhruva et al., 2012). It was found that the more the 
patients practiced pranayama, the greater the improvement in quality of life and symptom 
scores in those patients.. Moreover, the parameters of sleep disturbance, anxiety, and 
mental quality of life all attained or neared statistical significance. The main limitation of 
this study was the small sample size and, the study also may have been affected by 
selection bias, as well as dependence on self-reported results (Dhruva et al., 2012). This 
study provides a meaningful pilot study that delves into the therapeutic effects of yoga on 
improving side effects associated with chemotherapy treatment in cancer patients. 
However, due to the small sample size, larger studies are needed in order to garner more 
meaningful, as well as clinically relevant results. Overall, this study demonstrates that 
spiritual techniques, such as yoga, have the potential to be utilized in the clinical setting 
as an adjunct to chemotherapy treatment. 
 Mindfulness-based stress reduction is another spiritual technique being analyzed 
by researchers in order to determine its efficacy in reducing the adverse quality of life 
side effects associated with chemotherapy treatment. Hoffman et al. (2012) conducted a 
study that assessed a total of 229 women with stage 0 to stage 3 breast cancer following 
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surgery, chemotherapy, and radiotherapy treatment. The study participants were 
randomized to either an eight-week MBSR program or standard care. Patients enrolled in 
the MBSR program received instruction on how to perform several mindfulness-body 
techniques, such as yoga-based stretches, sitting meditation, and group discussions. 
Profile of Mood States and WHO five-item well-being questionnaire were both utilized to 
assess the study participants’ mood and well-being, respectively. Researchers collected 
data at three separate time periods during the study: week 0, week 8, and week 12. The 
authors observed that the group in the MBSR program demonstrated statistically 
significant improvements in both mood and well-being as compared to the control group. 
Moreover, the study participants in the MBSR program also showed improvements in 
anxiety, depression, anger, and fatigue, which are all side effects associated with 
chemotherapy treatment (Hoffman et al., 2012). This study was limited in several aspects. 
The main limitation of the study was the fact that following the eight-week MBSR 
program, the investigators did not follow-up with the study participants to ensure that 
they continually utilized MBSR techniques. Moreover, the study was potentially limited 
by its dependence on self-reported outcomes. Also, due to the fact that the study only 
enrolled patients with breast cancer, the generalizability of the data to patients with other 
types of cancers may not be relevant (Hoffman et al., 2012). It is also worth noting that 
patients were less likely to enroll in the study if they either had stage 3 breast cancer or 
received more chemotherapy, as compared to the study participants (Hoffman et al., 
2012). Overall, this study provides insight into the potential use of MBSR techniques 
within the hospital setting. However, further studies are needed in order to determine the 
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full efficacy of MBSR on improving the side effects associated with chemotherapy. 
Studies that focus on determining the efficacy of MBSR techniques on other types of 
cancer are needed in order to garner more relevant data. 	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DISCUSSION 	   Exercise, music therapy, and spirituality have each been shown to have significant 
potential as tools of palliative care for physicians to utilize when treating cancer patients 
receiving chemotherapy treatment. In terms of exercise, Andersen et al. (2013), Jacobsen 
et al. (2013), and Mishra et al. (2012) all discovered that exercise intervention, as an 
adjunct to chemotherapy treatment, led to a reduction in fatigue scores in cancer patients. 
Furthermore, the first two studies both found that exercise intervention alone was not 
sufficient in improving the quality of life of cancer patients receiving chemotherapy 
treatment (Andersen et al., 2013; Jacobsen et al., 2013). The results on how exercise 
intervention affects quality of life discovered by Mishra et al. contradict the results found 
in the other two studies. Andersen et al. (2013) and Jacobsen et al. (2013) both found that 
exercise intervention alone had no significant effect on quality of life of patients, yet 
Mishra et al. (2012) found that exercise intervention had a significant positive effect on 
quality of life. However, as compared to the studies conducted by both Andersen et al. 
and Jacobsen et al., the study conducted by Mishra et al. analyzed a greater number of 
patients, and thus may be more relevant to the general population. It is very likely that the 
limited number of participants that took part in the studies administered by both 
Andersen et al. (2013) and Jacobsen et al. (2013) resulted in a failure to find statistically 
significant results in terms of the correlation between exercise intervention and quality of 
life. 
 With regard to the most effective training regimen, the meta-analysis conducted 
by Mishra et al. (2012) found that high-intensity exercise resulted in greater 
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improvements in both fatigue and quality of life as compared to mild- to moderate-
intensity exercises. It is also worth noting that the study conducted by Andersen et al. 
(2013) also utilized high-intensity cardiovascular works as part of the training regimen 
administered to study participants, but the efficaciousness of high-intensity 
cardiovascular workouts versus mild- to moderate- intensity cardiovascular workouts was 
not analyzed. In terms of the length of time that exercise intervention should be utilized, 
it appears that the longer the length of the training regimen, the better the outcome. 
Jacobsen et al. (2013) observed that fatigue scores continued to improve from both 
baseline, as well as 6 weeks into a chemotherapy cycle, as measured at 12 weeks after 
chemotherapy had started. It is possible that fatigue scores improve to a greater extent 
over 12 weeks as compared to 6 weeks due to the fact that the longer time period allows 
for the cancer patients to better acclimate to the chemotherapy treatment, thus resulting in 
reduced fatigue over time. Moreover, the physiological changes that the body undergoes 
following a period of continual exercise might also play a contributing role to greater 
improvement in fatigue scores at 12 weeks as compared to 6 weeks. 
 Though exercise intervention has demonstrated an ability to improve both fatigue 
and quality of life in cancer patients undergoing chemotherapy treatment, its efficacy 
may not be the same in all cancer patients. The studies administered by Andersen et al. 
(2013), Jacobsen et al. (2013), and Mishra et al. (2012) each analyzed patients with 
varying types of cancers, but only the study by Mishra et al. explored which type of 
cancer benefited the most from exercise intervention as an adjunct to chemotherapy 
treatment. Further studies that focus on the effect of exercise intervention on patients with 
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a specific type of cancer undergoing chemotherapy treatment are needed in order to 
determine the full extent that exercise intervention produces its effects. Furthermore, the 
study conducted by Jacobsen et al. (2013) found that patients who underwent concurrent 
chemotherapy and radiation therapy treatment were less likely to enroll in their study. 
This discovery demonstrates that a patient’s willingness to utilize exercise intervention as 
an adjunct to chemotherapy treatment may be limited by the aggressiveness of the 
treatment that they must undergo. It is likely that more aggressive cancer treatments lead 
to both a greater extent of fatigue, as well as a greater reduction in quality of life scores in 
cancer patients resulting in both decreased motivation, as well as strength to integrate 
exercise into their daily lives. Further studies on advanced cancer patients undergoing 
aggressive cancer treatment are needed in order to determine how to incorporate a 
successful exercise regimen in the lives of advanced cancer patients. 
 While the effects of exercise as an adjunct to chemotherapy treatment have shown 
marked potential in improving the side effects associated with chemotherapy treatment in 
cancer patients, the efficacy of music therapy is less well documented in the scientific 
literature. Unlike the exercise intervention studies, the studies concerning music therapy 
utilized in this paper did not indicate any statistically significant change in fatigue score 
as a result of music therapy as an adjunct to chemotherapy treatment. However, the cited 
studies each demonstrated that music therapy could be used as a potential tool to reduce 
both anxiety and stress in cancer patients receiving chemotherapy (Lin et al., 2011; 
O’Callaghan et al., 2012; Romito et al., 2013). Music therapy appears to have perceived 
efficacy in aiding cancer patients in the reduction of fear, subsiding of depression, and 
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attainment of an identity. The role that music therapy plays in the lives of cancer patients 
is a critical one because it helps cancer patients cope with both their disease, as well as 
the difficult treatment associated with that disease. Moreover, as illustrated by Lin et al. 
(2011), music therapy appears to have marked efficacy in reducing anxiety in cancer 
patients that suffer from acute anxiety attacks. Further research that compares music 
therapy to other potential therapies would be needed in order to study the true efficacy of 
music therapy in reducing spontaneous anxiety attacks in cancer patients undergoing 
chemotherapy treatment. Overall, however, music therapy appears to have evident 
potential as a multi-use therapy treatment in cancer patients receiving chemotherapy 
treatment. 
 The manner in which music therapy should be administered to cancer patients as 
an adjunct to chemotherapy treatment is still up for debate. As cited by O’Callaghan et al. 
(2012), some of the patients receiving music therapy sessions found them uncomfortable. 
It is possible that if this study was conducted over a larger time span, the perceived 
discomfort with music therapy sessions would decrease as patients become more 
acclimated to the sessions, but further research is needed in order to determine how to 
properly administer music therapy sessions to cancer patients. Furthermore, both the 
length of the music therapy sessions, as well as the types of music utilized for music 
therapy have not been fully investigated. It is possible that music therapy could be 
utilized on a spontaneous basis whenever cancer patients start to feel either depressed or 
anxious. Moreover, as previous studies have demonstrated, preferred music, versus non-
preferred music, appears to have the greatest efficacy in reducing the side effects 
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associated with chemotherapy treatment. Thus, the integration of music therapy into the 
lives of cancer patients receiving chemotherapy treatment seems to be a matter of 
personal preference, and it would be essential for a patient’s clinician to determine the 
ideal manner in administering music therapy. 
 The main issue concerning the effectiveness of music therapy as a palliative care 
tool for cancer patients receiving chemotherapy treatment is that there is a lack of focus 
on the topic within the scientific community. One reason why many researchers may not 
be interested in investigating the effects of music therapy on cancer patients is because its 
desired effect on patients is subjective in nature, and thus it is difficult to ascertain the 
full extent that music therapy imposes on both anxiety and depression in patients. 
Secondly, most scientific research is focused on finding new ways to treat a patient’s 
cancer, in hopes of developing a cure. Yet, it is still imperative that both the healthcare, 
as well as the scientific communities, concentrate on finding ways to treat patients 
holistically, so that clinicians can effectively treat a patient’s disease, as well as the side 
effects that are procured due to having that disease. Music therapy offers a potential 
avenue for physicians to utilize when treating patients who either prefer alternative 
medicines over pharmacologic compounds, or are seeking novel approaches to treat the 
side effects associated with chemotherapy treatment. 
 Similar to how music therapy could be utilized to improve the quality of life and 
well-being of patients, spirituality has also been studied as a potential tool to help patients 
improve their quality of life while undergoing chemotherapy treatment. Spirituality, in 
the context of the studies explored in this paper, is concerned with utilizing an array of 
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different techniques in order to reduce stress and anxiety. This paper looked at studies 
that investigated the effects of religion, yoga, and MBSR on improving a patient’s quality 
of life. The study conducted by Mesquita et al. (2013) explored how religion can reduce 
stress and anxiety in cancer patients receiving chemotherapy treatment. The most 
significant finding of the study was that the effect of religion on patients was dependent 
upon the role that spirituality played in the patients’ lives. The more religious or spiritual 
a person was, the more that person tended to utilize spirituality in a positive way in order 
to improve their quality of life. Interestingly, even if a person was spiritual or religious, 
and utilized spirituality in a positive manner, it was found that if the side effects of 
chemotherapy treatment did not subside, that person tended to starts to utilize spirituality 
in a negative manner (Mesquita et al., 2013). The most likely explanation for this effect is 
that if a patient fails to see improvement in quality of life after relying upon spirituality to 
help cope with their disease, the patient most likely begins to become more pessimistic 
towards their beliefs. Though religion appears to play a role in improving the lives of 
patients afflicted by cancer and undergoing treatment, its efficacy is limited, and its 
potential as a viable option as a palliative care tool is reliant on the individual receiving 
treatment. Thus, it is important that studies focus on helping physicians develop 
guidelines that allow them to take a patient’s spirituality history in order to determine if 
spirituality can be utilized as a potential treatment option for the adverse side effects 
associated with chemotherapy treatment. 
 Unlike the questionable efficacy of religion on improving the quality of life of 
cancer patients, the efficacy that yoga and MBSR offer to patients afflicted with cancer 
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and undergoing chemotherapy treatment is much more definitive. Both Dhruva et al. 
(2012) and Hoffman et al. (2012) discovered that utilizing either yoga or MBSR, 
respectively, while patients underwent chemotherapy treatment, resulted in significant 
improvements in quality of life for those patients. Moreover, Hoffman et al. (2012) found 
statistically significant improvements in fatigue scores as well, after patients utilized 
MBSR techniques. The effectiveness of both yoga and MBSR most likely stems from the 
fact that both can be utilized in order to relax a person both mentally and physically. 
Compared to exercise, which also demonstrated significant improvements in fatigue 
scores in cancer patients undergoing chemotherapy treatment, MBSR offers less 
strenuous exercises that can be utilized in order to help improve the quality of life of 
patients.  
Similar to music therapy, however, there are only a limited number of scientific 
papers concerned with the effects of spirituality on cancer patients undergoing 
chemotherapy treatment. Moreover, the studies investigated within this paper were 
relatively small, and did not encompass all of the various types of cancers, so the data 
from these studies may not be completely relevant. Larger studies that delve into how to 
properly utilize spirituality to treat cancer patients receiving chemotherapy, how to 
properly incorporate spirituality into a patient’s treatment regimen, and how to 
definitively determine its effectiveness as an adjunct to chemotherapy treatment are 
needed in order to fully understand the role that spirituality can potentially play as a 
palliative care tool. 
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Overall, exercise, music therapy, and spirituality offer promise in aiding the fight 
against cancer. Exercise, music therapy, and spirituality have each demonstrated, to some 
extent, potential in improving fatigue, quality of life, or both fatigue and quality of life in 
cancer patients undergoing chemotherapy treatment. One of the main issues that is 
preventing the utilization of exercise, music therapy, and spirituality in treating cancer 
patients receiving chemotherapy treatment is the fact that the scientific community is 
more focused on finding a cure for cancer, as opposed to findings ways to help improve 
the side effects associated with chemotherapy treatment. As treatment options for cancer 
improve, there will be a shift in focus on finding ways to help patients improve their 
quality of life. Clinically, it is imperative that physicians attempt to treat both a patient’s 
disease, as well as the side effects associated with either the disease itself or the treatment 
of that disease due to the fact that sometimes the side effects of chemotherapy treatment 
can be as detrimental as the disease itself. Finding ways to allow patients to still maintain 
their daily lives is essential to the general well-being of the patients. As noted above, 
further research is needed in order gain a better understanding on the use of exercise 
intervention, music therapy, and spirituality as an adjunct to chemotherapy treatment. It 
would be interesting for further studies to delve into the integration of all three 
interventions in order to figure out the most effective treatment plan for cancer patients 
undergoing chemotherapy treatment. The future of cancer research is promising, and over 
the next decade further research will allow for cancer patients to better cope with their 
disease.	  
  
	  50 
REFERENCES 
 
American Music Therapy Association. (n.d.). History of Music Therapy. Retrieved June 
12, 2014, from http://www.musictherapy.org/about/history/ 
 
Ancoli-Israel, S., Liu, L., Rissling, M., Natarajan, L., Neikrug, A. B., Palmer, B. W., … 
Maglione, J. (2014). Sleep, fatigue, depression, and circadian activity rhythms in 
women with breast cancer before and after treatment: a 1-year longitudinal study. 
Supportive Care in Cancer: Official Journal of the Multinational Association of 
Supportive Care in Cancer. doi:10.1007/s00520-014-2204-5 
 
Andersen, C., Rørth, M., Ejlertsen, B., Stage, M., Møller, T., Midtgaard, J., … Adamsen, 
L. (2013). The effects of a six-week supervised multimodal exercise intervention 
during chemotherapy on cancer-related fatigue. European Journal of Oncology 
Nursing, 17(3), 331–339. doi:10.1016/j.ejon.2012.09.003 
 
Bernacki R.E., Meier D.E. (2012). Chapter 215. Principles of Palliative Care. In McKean 
S.C., Ross J.J., Dressler D.D., Brotman D.J., Ginsberg J.S. (Eds), Principles and 
Practice of Hospital Medicine. Retrieved June 11, 2014 from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=496&Se
ctionid=41304204. 
 
Boers, D., Zeegers, M. P. A., Swaen, G. M., Kant, I. J., & Brandt, P. A. van den. (2005). 
The influence of occupational exposure to pesticides, polycyclic aromatic 
hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate 
cancer: a prospective cohort study. Occupational and Environmental Medicine, 
62(8), 531–537. doi:10.1136/oem.2004.018622 
 
Bonelli, R. M., & Koenig, H. G. (2013). Mental disorders, religion and spirituality 1990 
to 2010: a systematic evidence-based review. Journal of Religion and Health, 52(2), 
657–673. doi:10.1007/s10943-013-9691-4 
 
Carson, R., & Darling, L. (1962). Silent spring. Boston: Houghton Mifflin ;. 
 
Chalise, H. N. (n.d.). Self-Care Practices and Their Perceived Effectiveness among 
Fatigued Cancer Patients in Nepal. Retrieved April 4, 2014, from 
http://www.academia.edu/5206397/Self-
Care_Practices_and_Their_Perceived_Effectiveness_among_Fatigued_Cancer_Patie
nts_in_Nepal 
 
Chan, M. F., Wong, Z. Y., Onishi, H., & Thayala, N. V. (2012). Effects of music on 
depression in older people: a randomised controlled trial. Journal of Clinical 
Nursing, 21(5-6), 776–783. doi:10.1111/j.1365-2702.2011.03954.x	  
	  51 
Chu E, Sartorelli A.C. (2012). Chapter 54. Cancer Chemotherapy. In Katzung B.G., 
Masters S.B., Trevor A.J. (Eds), Basic & Clinical Pharmacology, 12e. Retrieved 
June 11, 2014 from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=388&Se
ctionid=45764280.	  	  
Clark, D. (2007). From margins to centre: a review of the history of palliative care in 
cancer. The Lancet Oncology, 8(5), 430–8. doi:10.1016/S1470-2045(07)70138-9 
 
Crowe, B. J. (2007). Effective clinical practice in music therapy: music therapy for 
children, adolescents, and adults with mental disorders. Silver Spring, Md.: 
American Music Therapy Association. 
 
DeBattista C (2012). Chapter 30. Antidepressant Agents. In Katzung B.G., Masters S.B., 
Trevor A.J. (Eds), Basic & Clinical Pharmacology, 12e. Retrieved June 11, 2014 
from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=388&Se
ctionid=45764252. 
 
DeVita, V. T., & Chu, E. (2008). A History of Cancer Chemotherapy. Cancer Research, 
68(21), 8643–8653. doi:10.1158/0008-5472.CAN-07-6611 
 
Dhruva, A., Miaskowski, C., Abrams, D., Acree, M., Cooper, B., Goodman, S., & Hecht, 
F. M. (2012). Yoga Breathing for Cancer Chemotherapy–Associated Symptoms and 
Quality of Life: Results of a Pilot Randomized Controlled Trial. The Journal of 
Alternative and Complementary Medicine, 18(5), 473–479. 
doi:10.1089/acm.2011.0555 
 
Ediebah, D. E., Coens, C., Zikos, E., Quinten, C., Ringash, J., King, M. T., … Bottomley, 
A. (2014). Does change in health-related quality of life score predict survival? 
Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer, 110(10), 
2427–2433. doi:10.1038/bjc.2014.208 
 
Erickson, J. M., Adelstein, K. E., & Letzkus, L. C. (2014). A Feasibility Study to 
Measure Physical Activity, Fatigue, Sleep–Wake Disturbances, and Depression in 
Young Adults During Chemotherapy. Journal of Adolescent and Young Adult 
Oncology, 3(1), 37–41. doi:10.1089/jayao.2013.0028 
 
Elrick, H. (1996). Exercise Is Medicine. The Physician and Sportsmedicine, 24(2), 0. 
doi:10.3810/psm.1996.02.1234 
 
Gaertner, J., Knies, A., Nauck, F., Voltz, R., Becker, G., & Alt-Epping, B. (2014). 
“Curative” treatments and palliative care: the lack of consensus. Current Opinion in 
Oncology. doi:10.1097/CCO.0000000000000099 
	  52 
Gutgsell, K. J., Schluchter, M., Margevicius, S., DeGolia, P. A., McLaughlin, B., Harris, 
M., … Wiencek, C. (2013). Music therapy reduces pain in palliative care patients: a 
randomized controlled trial. Journal of Pain and Symptom Management, 45(5), 822–
831. doi:10.1016/j.jpainsymman.2012.05.008 
 
Hoffman, C. J., Ersser, S. J., Hopkinson, J. B., Nicholls, P. G., Harrington, J. E., & 
Thomas, P. W. (2012). Effectiveness of Mindfulness-Based Stress Reduction in 
Mood, Breast- and Endocrine-Related Quality of Life, and Well-Being in Stage 0 to 
III Breast Cancer: A Randomized, Controlled Trial. Journal of Clinical Oncology, 
30(12), 1335–1342. doi:10.1200/JCO.2010.34.0331 
 
Holmes, M. D., Chen, W. Y., Feskanich, D., Kroenke, C. H., & Colditz, G. A. (2005). 
Physical activity and survival after breast cancer diagnosis. JAMA: The Journal of 
the American Medical Association, 293(20), 2479–2486. 
doi:10.1001/jama.293.20.2479 
 
Jacobsen, P. B., Phillips, K. M., Jim, H. S. L., Small, B. J., Faul, L. A., Meade, C. D., … 
Wilson, R. W. (2013). Effects of self-directed stress management training and home-
based exercise on quality of life in cancer patients receiving chemotherapy: a 
randomized controlled trial. Psycho-Oncology, 22(6), 1229–1235. 
doi:10.1002/pon.3122 
 
Korczak, D., Wastian, M., & Schneider, M. (2013). Music therapy in palliative setting. 
GMS Health Technology Assessment, 9. doi:10.3205/hta000113 
 
Laiho, S. (2004). The Psychological Functions of Music in Adolescence. Nordic Journal 
of Music Therapy, 13(1), 47–63. doi:10.1080/08098130409478097 
 
Lin, M.-F., Hsieh, Y.-J., Hsu, Y.-Y., Fetzer, S., & Hsu, M.-C. (2011). A randomised 
controlled trial of the effect of music therapy and verbal relaxation on 
chemotherapy-induced anxiety. Journal of Clinical Nursing, 20(7-8), 988–999. 
doi:10.1111/j.1365-2702.2010.03525.x 
 
Li, Q., Lin, Y., Qiu, Y., Gao, B., & Xu, Y. (2014). The assessment of health-related 
quality of life and related factors in Chinese elderly patients undergoing 
chemotherapy for advanced cancer: A cross-sectional study. European Journal of 
Oncology Nursing: The Official Journal of European Oncology Nursing Society. 
doi:10.1016/j.ejon.2014.03.005 
 
Mesquita, A. C., Chaves, É. de C. L., Avelino, C. C. V., Nogueira, D. A., Panzini, R. G., 
Carvalho, E. C. de, … Carvalho, E. C. de. (2013). The use of religious/spiritual 
coping among patients with cancer undergoing chemotherapy treatment. Revista 
Latino-Americana de Enfermagem, 21(2), 539–545. doi:10.1590/S0104-
11692013000200010 
	  53 
Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P. M., Berlanstein, D. R., & Topaloglu, 
O. (2012). Exercise interventions on health-related quality of life for people with 
cancer during active treatment. The Cochrane Database of Systematic Reviews, 8, 
CD008465. doi:10.1002/14651858.CD008465.pub2 
 
Moreira-Almeida, A., Koenig, H. G., & Lucchetti, G. (2014). Clinical implications of 
spirituality to mental health: review of evidence and practical guidelines. Revista 
Brasileira de Psiquiatria (São Paulo, Brazil: 1999), 36(2), 176–182. 
 
Morrison, S., Meier, D., Augustin, R., Souvanna, P., Appellof, M., Morgan, L., et al. 
(2011, May 1). America's Care of Serious Illness: A State-by-State Report Card on 
Access to Palliative Care in our Nation's Hospitals. . Retrieved June 12, 2014, from 
http://reportcard.capc.org/pdf/state-by-state-report-card.pdf 
 
Murray R.K., Jacob M, Varghese J (2012). Chapter 55. Cancer: An Overview. In Murray 
R.K., Bender D.A., Botham K.M., Kennelly P.J., Rodwell V.W., Weil P (Eds), 
Harper's Illustrated Biochemistry, 29e. Retrieved June 11, 2014 from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=389&Se
ctionid=40142535. 
 
National Cancer Institute - Comprehensive Cancer Information .... (2014, April 15). . 
Retrieved June 12, 2014, from http://www.cancer.gov/ 
 
Nayak, S., B. L. W. (2000). Effect of music therapy on mood and social interaction 
among individuals with acute traumatic brain injury and stroke. Rehabilitation 
Psychology, 45(3), 274–283. doi:10.1037/0090-5550.45.3.274 
 
O’Callaghan, C., Barry, P., & Thompson, K. (2012). Music’s relevance for adolescents 
and young adults with cancer: a constructivist research approach. Supportive Care in 
Cancer, 20(4), 687–697. doi:10.1007/s00520-011-1104-1 
 
Peuckmann-Post, V., Elsner, F., Krumm, N., Trottenberg, P., & Radbruch, L. (1996). 
Pharmacological treatments for fatigue associated with palliative care. In Cochrane 
Database of Systematic Reviews. John Wiley & Sons, Ltd. Retrieved from 
http://onlinelibrary.wiley.com.ezproxy.bu.edu/doi/10.1002/14651858.CD006788.pu
b2/abstract 
 
Puchalski, C. M. (2012). Spirituality in the cancer trajectory. Annals of Oncology, 
23(suppl 3), 49–55. doi:10.1093/annonc/mds088 
 
Rew, L., & Wong, Y. J. (2006). A systematic review of associations among 
religiosity/spirituality and adolescent health attitudes and behaviors. The Journal of 
Adolescent Health: Official Publication of the Society for Adolescent Medicine, 
38(4), 433–442. doi:10.1016/j.jadohealth.2005.02.004 
	  54 
Romito, F., Lagattolla, F., Costanzo, C., Giotta, F., & Mattioli, V. (2013). Music therapy 
and emotional expression during chemotherapy. How do breast cancer patients feel? 
European Journal of Integrative Medicine, 5(5), 438–442. 
doi:10.1016/j.eujim.2013.04.001 
 
Ropper, A., & Samuels, M. (2009). Adam's and victor's principles of neurology. (9 ed.). 
The McGraw-Hill Companies, Inc. Retrieved from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=354&Se
ctionid=40236335. 
 
Segal, R., Evans, W., Johnson, D., Smith, J., Colletta, S., Gayton, J., … Reid, R. (2001). 
Structured Exercise Improves Physical Functioning in Women With Stages I and II 
Breast Cancer: Results of a Randomized Controlled Trial. Journal of Clinical 
Oncology, 19(3), 657–665. 
 
Sharkey K.A., Wallace J.L. (2011). Chapter 46. Treatment of Disorders of Bowel 
Motility and Water Flux; Anti-Emetics; Agents Used in Biliary and Pancreatic 
Disease. In Brunton L.L., Chabner B.A., Knollmann B.C. (Eds), Goodman & 
Gilman's The Pharmacological Basis of Therapeutics, 12e. Retrieved June 11, 2014 
from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=374&Se
ctionid=41266256. 
 
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014). Cancer statistics, 2014. CA: A Cancer 
Journal for Clinicians, 64(1), 9–29. doi:10.3322/caac.21208 
 
Van Aalst-Cohen, E. S., Riggs, R., & Byock, I. R. (2008). Palliative Care in Medical 
School Curricula: A Survey of United States Medical Schools. Journal of Palliative 
Medicine, 11(9), 1200–1202. doi:10.1089/jpm.2008.0118 
 
Wang, X. S., Zhao, F., Fisch, M. J., O’Mara, A. M., Cella, D., Mendoza, T. R., & 
Cleeland, C. S. (2014). Prevalence and characteristics of moderate to severe fatigue: 
a multicenter study in cancer patients and survivors. Cancer, 120(3), 425–432. 
doi:10.1002/cncr.28434 
 
Young, W. C., Nadarajah, S. R., Skeath, P. R., & Berger, A. M. (2014). Spirituality in the 
context of life-threatening illness and life-transforming change. Palliative & 
Supportive Care, 1–8. doi:10.1017/S1478951514000340 
 
Yuen C, Giralt S (2011). Chapter 12. Allogeneic Transplantation. In Kantarjian H.M., 
Wolff R.A., Koller C.A. (Eds), The MD Anderson Manual of Medical Oncology, 2e. 
Retrieved June 11, 2014 from 
http://accessmedicine.mhmedical.com.ezproxy.bu.edu/content.aspx?bookid=379&Se
ctionid=39902035. 
	  55 
CURRICULUM VITAE 
Michael Caputo 
43 Claypit Road 
Staten Island, NY 10309 
Year of Birth: 1991 
Contact Info: (Phone) 347-225-6499 
(email) mikecaps@bu.edu 	  
 
Education                                     
- M.S. in Medical Sciences, Boston University School of Medicine, September 
2014 (expected) 
- B.A. in Biology, Boston University, May 2013 
o GPA: 3.65/4.0 
o Magna Cum Laude 
__________________________________________________________________________________ 
Awards & Honors 
- Patriot League Honor Roll (Fall 2013)  
- Senior Scholar-Athlete Award (Spring 2013)  
- America East Commissioner’s Honor Roll (Fall 2009 to May 2013)  
- America East All-Academic Team (Fall 2012)  
- Boston University Dean’s List (Fall 2009 to May 2012)  
- National Honor Society of Collegiate Scholars 
________________________________________________________________________ 
Work Experience 
- Excel Elevators: Administrative Assistant (May 2011 to August 2011, July 2013 
to August 2013) 
o Organize new clients into easily accessible and understandable excel file. 
o Dispatched jobs to elevator mechanics. 
o Developed program that was responsible for keeping track of elevator jobs that were 
not completed. 
o Created excel spreadsheet for invoices, as well as elevator violations that needed 
attention. 
- NYC Parks Department: Maintenance Worker (July 2010 to August 2010) 
o Maintained cleanliness of Wolfe’s Pond Park. 
o Assisted parks department employees in improving quality of park. 
________________________________________________________________________ 
Volunteer Experience 
- Shadowing Experience at Staten Island University Hospital (May 2011 to August 
2011) 
o Shadowed several emergency room physicians at SIUH. 
o Assisted nurses with retrieval of necessary medical equipment. 
- Brigham & Women’s Hospital (MCEP) (November 2010 to May 2011) 
o Transferred blood and plasma samples to the correct locations within hospital. 
	  56 
o Assisted security guards in making sure that the correct people were gaining access 
to the maternity ward. 
- Richmond University Medical Center Volunteer (June 2008 to August 2008) 
o Assisted physical therapists while treating their patients. 
 
________________________________________________________________________ 
Research Experience 
- Cervical Cancer Research – Volunteer Research Assistant, CSI Banerjee Lab 
(May 2012 to September 2012) 
o Performed western blot analyses, focusing on the ability for curcumin-based vaginal 
cream to decrease expression of pro-cancer protein EGFR. 
o Performed tissue cultures of HeLa cell line (cervical cancer cell line). 
o Treated HeLa cell line with differing doses of curcumin-based vaginal cream to study 
dose-dependent effect of cream. 
o Performed PCR analysis, as well as cell counting. 
________________________________________________________________________ 
Presentations 
- CSI Biochemistry Conference, Staten Island, NY (July 2012) 
o Explained classification system of Papillomavirus. 
__________________________________________________________________________________ 
Leadership and Activites 
- Cross Country/Track & Field (Division 1) (Fall 2009 to Fall 2013) 
o Co-captain of the track & field distance group for Fall 2013 Cross Country Season. 
o Member of the 2010 America East Cross Country Championship team. 
- BU Premedical Society (Fall 2009 to May 2013) 
 
